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1. Introduction 
Recently, Goldberg et al. [l] have studied the 
relation of cyclic GMP with regulatory processes in 
various systems. According to the concept of Yin-Yang, 
they hypothesized that the intracellular concentration 
of cyclic AMP and of cyclic GMP are correlated and 
that these concentrations vary inversely in numerous 
regulatory events. This hypothesis implies that the 
system under study is modulated by two antagonistic 
effecters. 
Many of the biological effects of thyroid stimulating 
hormone (TSH) on the thyroid appear to be mediated 
by an increase of the synthesis of cyclic AMP (CAMP) [2] 
Qn the contrary cyclic AMP is not implicated in the 
32P incorporation into phospholipids evoked either by 
TSH [3,4] or by acetylcholine. This latter result is 
supported by the fact that acetylcholine does not 
increase cyclic AMP concentrations in thyroid slices [SJ . 
Moreover, cyclic GMP levels are significantly increased 
by acetylcholine [6] .The present studies demonstrate 
that acetylcholine antagonizes the increase of cyclic 
AMP promoted by TSH and that prostaglandins Fa are 
implicated in this process. 
2. Materials and methods 
Pig thyroid slices (about 100 mg) were preincubated 
for 30 mm at 37°C in 2 ml of Krebs-Ringer phosphate 
buffer (KRP) with glucose (1 mg/ml) in presence or 
absence of dibutyryl cyclic GMP (5 X lo-’ or lob4 M) 
or indomethacin (10 pg/ml). 
* With the technical assistance of Mrs Legue. 
North-Holland Publishing Company - Amsterdam 
Then the slices were transferred into 2 ml of the 
same buffer containing theophyllin 1 0W2 M) and, ac- 
cording to the assays, various effecters: TSH (20 mu/ml), 
acetylcholine chloride (5.5 X lo-‘M) and eserine 
sulfate (3 X 10V4 M), atropine sulfate (1 O-’ M), indo- 
methacin (10 pg/ml), PGF2a (3 X lo-’ or 6 X 10e5M), 
DBcGMP (5 X 10 -5 or 10b4M). After incubation 
(15 min), the slices were homogenized in 2 ml of tri- 
chloracetic acid (TCA) 5% and the CAMP content was 
assayed according to the method of Gilman [7 j as 
previously described [S] . All determinations were 
performed in triplicate. The comparisons between 
assays and standards were assessed by the t-test of 
Student [9]. 
One single gland was used for all assays of each 
experiment. The experiments were repeated several 
times with identical, significant results. 
A@ -2’-O-Dibutyryl-3’,5’-cyclic GMP (DBc-GMP) 
was purchased from Boehringer (Mannheim GmbH lot 
No. 70 143 12) Eserine sulfate from Sigma, atropine 
sulfate from Merck, acetylcholine chloride from Lematte 
et Boinot laboratories, Paris. Prostaglandin F,a (PGF2cu) 
was a gift from Dr Pike (Upjohn Co.). Thyreostimulin 
(TSH) was a gift from Endocrinology Study Section 
(NIH, Bethesda). Indomethacin was a gift from Merck, 
Sharp and Dohme Laboratories. 
3. Results 
Fig. 1 shows that acetylcholine decreases cyclic AMP 
accumulation induced by TSH in pig thyroid slices. The 
control levels of endogenous cyclic AMP were not altered 
by acetylcholine. The inhibitory effect of acetylcholine 
on TSH-induced cyclic AMP accumulation is reversed 
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Fig. 3. Inhibition by indomethacin of the action of acetyl- 
choline on the accumulation of CAMP. TSH = 20 mu/ml 
AC. Choline: acetylcholine 5.5 X 10-s M + eserine 3 X 10d4 M 
Indomethacin 10 pg/ml (during the preincubation and incu- 
bation) TSH p < 0.001 vs. control INDO N.S. vs. control 
AC. Choline N.S. vs. control INDO + AC. Choline N.S. vs. control 
INDO + TSH p < 0.05 vs. TSH AC. Choline + TSH p < 0.01 
vs. TSH INDO + TSH + AC. Choline p < 0.05 vs. TSH INDO + 
AC. Choline + TSH N.S. vs. INDO + TSH. 
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Fig. 1. Action of acetylcholine on the stimulation of CAMP 
production by TSH. TSH = 10 mu/ml. AC. Choline: acetyl- 
choline 5.5 x lo-’ M + eserine 3 X lO-+M TSH + AC. Choline 
P < 0.01 vs. TSH TSH P < 0.001 vs. control. AC. Choline N.S. 
vs. control. 
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Fig. 2. Inhibition by atropine of the decrease of the accumu- 
lation of CAMP induced by acetylcholine. TSH = 20 mu/ml 
AC. Choline: acetylcholine 5.5 X 10m5 M + eserine 3 X 1 Oe4 M 
atropine lo-’ M TSH + AC. Choline p < 0.05 vs. TSH TSH p 
< 0.001 vs. control TSH + AC. Choline + atropine N.S. vs. TSH. 
I 
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Fig. 4. Action of PGF,(r on the accumulation of CAMP stimula- 
ted by TSH. TSH = 20 mlJ/ml PGF, Q 3 X 1 O- ’ M or 6 X 
10w5M TSHp < O.‘OOl vs. control TSH + PFG,ol3 X 10m5M 
N.S. vs. TSH TSH + PGF,(u 6 X lo-‘M p .< 0.01 vs. TSH. 
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by atropine, indicating the specificity of the acetyl- 
choline action (fig. 2). 
Fig. 3 shows that this effect of acetylcholine is 
completely inhibited by the tissue preincubation in the 
presence of indomethacin. This inhibitor of prostaglandin 
synthetase [9], decreases by about 25% the cyclic AMP 
accumulation induced by TSH. The same value is 
obtained in the assay containing TSH + acetylcholine 
+ indomethacin. PGFzcq without effect on basal 
cyclic AMP levels in the thyroi’d, decreases in a dose 
dependent manner the accumulation of the cyclic 
nucleotide promoted by TSH (fig. 4). 
At the two levels tested (5 X lo-‘M and 10m4M) 
dibutyryl cyclic GMP (DBc-GMP) is without effect 
either on the basal or on the TSH stimulated accumu- 
lation of cyclic AMP. 
4. Discussion 
The effect of acetycholine which we describe here, 
is similar to those studied in the heart [ 11, 121, in the 
intestinal smooth muscle [ 121, in the brain [ 121, 
in estrogen treated rat uterus [ 131, in myocardial 
tissue stimulated by isoproterenol or glucagon [ 141 
or in rat lung slices [ 151 . The control levels of 
endogenous cyclic AMP were not altered by acetyl- 
choline, but the TSH induced rise in cyclic AMP 
was decreased. The suppression of this effect by 
indomethacin, an inhibitor of prostaglandin synthe- 
tase, shows the implication of endogenous prostaglan- 
dins in the inhibitory role of acetylcholine. We have 
shown previously [8] that the TSH stimulation of the 
thyroi’d adenyl cyclase is amplified by PGE2 synthesized 
from phospholipidic arachidonate. Two hypotheses can 
be made about the mode of action of the prostaglandins 
mediating the acetylcholine action: a dose related bipha- 
sic effect of PGE as suggested by Burke’s results [ 161 or 
an antagonistic effect of PGFa, which has been claimed 
to be associated with the cyclic GMP generation [ 171. 
Results reported in fig. 4 support the second explana- 
tion. PGFa, devoid of action on the basal level of CAMP, 
as reported by several authors [ 18-201, mimics the 
action of acetylcholine. We believe that the role of 
acetylcholine would be to modify the balance between 
endogenous PGEz and PGF2q thus increasing the 
concentration of the latter. 
We do not know how to interpret the failure of 
dibutyryl cyclic GMP in reproducing the acetylcholine 
effect. Perhaps this is due to the fact that the cyclic 
GMP derivative does not easily enter the cells. An 
alternative explanation would be that the enhancement 
of cyclic GMP, concentration, consecutive to acetylche 
line action [6], is not directly related to a depression of 
cyclic AMP. Therefore cyclic GMP would be an anta- 
gonist of the cyclic AMP action and would not de- 
crease its concentration. 
Nevertheless the preliminary results reported here 
strongly support Goldberg’s concept of the antagonism 
between cyclic AMP and cyclic GMP, but various para- 
meters have not yet been tested, for example: the 
ability of TSH to suppress cholinergically stimulated 
cyclic GMP levels. 
Experiments are in progress to establish the 
relationship between cyclic GMP and prostaglandins 
under acetylcholine stimulation. 
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